arrow
T

Trever G. Bivona

University of California San Francisco
H指数:67
被引数:2.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pan-RAF inhibitor exarafenib targets BRAF class II/III NSCLC and reveals ARAF-KSR1 resistance and combination strategies

泛RAF抑制剂exarafenib靶向BRAF II/III类NSCLC并揭示ARAF-KSR1耐药性和联合策略

2026-02-070
OAAI
Myeloid-mesenchymal crosstalk drives ARG1dependent profibrotic metabolism via ornithine in lung fibrosis

骨髓间充质串扰通过鸟氨酸在肺纤维化中驱动arg1依赖性纤维化代谢

2025-11-031
OA
Targeting WEE1 to Overcome ARID1A Mutation-Driven Osimertinib Resistance in EGFR-Mutant Lung Cancer

靶向WEE1以克服ARID1A突变驱动的奥希替尼耐药性在EGFR突变型肺癌中

2025-06-130
OAAI
CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

CTLA4阻断消除KEAP1/STK11-related对PD-(L)1抑制剂的抗性

Nature
IF48.5
2024-10-090
OAAI
Quantification of cerebrospinal fluid tumor DNA in lung cancer patients with suspected leptomeningeal carcinomatosis

疑似脑膜癌病的肺癌患者脑脊液肿瘤DNA的定量分析

2024-05-284
OAAI
Focal adhesion kinase-YAP signaling axis drives drug-tolerant persister cells and residual disease in lung cancer
2024-05-0310
OAAI
PERCEPTION predicts patient response and resistance to treatment using single-cell transcriptomics of their tumors

PERCEPTION使用肿瘤的单细胞转录组学预测患者对治疗的反应和抵抗力

2024-04-188
OA
The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance
2023-12-0419
OAAI